Last $3.29 USD
Change Today -0.03 / -0.90%
Volume 2.7M
EXEL On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael M. Morrissey Ph.D.

Chief Executive Officer, President and Director, Exelixis, Inc.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 2 different organizations across 2 different industries.

See Board Relationships
52$3,344,880
As of Fiscal Year 2012

Background*

Mr. Michael M. Morrissey, Ph.D. has been the Chief Executive Officer and President of Exelixis, Inc., since July 2010. Dr. Morrissey served as the President of Research and Development at Exelixis Inc., since January 4, 2007. Dr. Morrissey served as an Executive Vice President of Discovery of Exelixis Inc., from January 2006 to December 2006 and its Senior Vice President of Discovery Research from January 2003 to December 2005. Dr. Morrissey served as Vice President ...

Read Full Background

Corporate Headquarters*

210 East Grand Avenue
South San Francisco, California 94080

United States

Phone: 650-837-7000
Fax: 650-837-8300

Board Members Memberships*

2010-Present
Chief Executive Officer, President and Director

Education*

PhD
Harvard University
BS
Concordia University, Wisconsin

Other Affiliations*

Annual Compensation*

Salary$618,682
Bonus$438,286
Total Annual Compensation$1,056,968

Stock Options*

All Other Compensation$7,500
Exercisable Options1,389,583
Exercisable Options Value$2,156
Unexercisable Options787,417
Unexercisable Options Value$94
Total Value of Options$2,250
Total Number of Options2,445,000

Total Compensation*

Total Annual Cash Compensation$1,064,468
Total Short Term Compensation$1,056,968
Other Long Term Compensation$7,500
Total Calculated Compensation$3,344,880
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EXEL:US $3.29 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
Cell Therapeutics, Inc.
$1.3M
Robert I. Blum Chief Executive Officer, President, Director and Chief Executive of the Biopharmaceutical Concern
Cytokinetics, Incorporated
$555.0K
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Werner Lanthaler MBA/MPAChief Executive Officer
Evotec AG
€601.0K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EXELIXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.